SPINK8
gene geneOn this page
Summary
SPINK8 (serine peptidase inhibitor Kazal type 8 (putative), HGNC:33160) is a protein-coding gene on chromosome 3p21.31, encoding Serine protease inhibitor Kazal-type 8 (P0C7L1). Probable serine protease inhibitor.
Predicted to enable serine-type endopeptidase inhibitor activity. Predicted to be located in extracellular region.
Source: NCBI Gene 646424 — RefSeq curated summary.
At a glance
- GWAS associations: 6
- Clinical variants (ClinVar): 9 total
- MANE Select transcript:
NM_001080525
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:33160 |
| Approved symbol | SPINK8 |
| Name | serine peptidase inhibitor Kazal type 8 (putative) |
| Location | 3p21.31 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000229453 |
| Ensembl biotype | protein_coding |
| Entrez | 646424 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 2 protein_coding
ENST00000434006, ENST00000944525
RefSeq mRNA: 1 — MANE Select: NM_001080525
NM_001080525
CCDS: CCDS46822
Canonical transcript exons
ENST00000434006 — 8 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001607892 | 48319497 | 48319618 |
| ENSE00001647485 | 48328275 | 48328354 |
| ENSE00001705286 | 48321025 | 48321074 |
| ENSE00001724206 | 48306842 | 48307003 |
| ENSE00001784716 | 48309904 | 48309946 |
| ENSE00003924019 | 48333535 | 48333661 |
| ENSE00003927527 | 48332366 | 48332471 |
| ENSE00003931667 | 48329153 | 48329274 |
Expression profiles
Bgee: expression breadth ubiquitous, 105 present calls, max score 93.52.
Top tissues by expression
127 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 93.52 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 84.21 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 76.76 | gold quality |
| ganglionic eminence | UBERON:0004023 | 68.61 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 67.53 | gold quality |
| ventricular zone | UBERON:0003053 | 66.77 | gold quality |
| esophagus mucosa | UBERON:0002469 | 66.61 | gold quality |
| bone marrow | UBERON:0002371 | 65.17 | gold quality |
| blood | UBERON:0000178 | 64.86 | gold quality |
| Ammon’s horn | UBERON:0001954 | 64.23 | gold quality |
| granulocyte | CL:0000094 | 62.28 | gold quality |
| hypothalamus | UBERON:0001898 | 60.77 | gold quality |
| substantia nigra | UBERON:0002038 | 60.35 | gold quality |
| amygdala | UBERON:0001876 | 60.16 | gold quality |
| temporal lobe | UBERON:0001871 | 59.69 | gold quality |
| primary visual cortex | UBERON:0002436 | 57.53 | gold quality |
| spleen | UBERON:0002106 | 56.33 | gold quality |
| putamen | UBERON:0001874 | 54.34 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 53.62 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 53.56 | gold quality |
| cerebellar cortex | UBERON:0002129 | 53.08 | gold quality |
| brain | UBERON:0000955 | 53.07 | gold quality |
| cerebellum | UBERON:0002037 | 53.07 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 52.93 | gold quality |
| caudate nucleus | UBERON:0001873 | 52.74 | gold quality |
| cerebral cortex | UBERON:0000956 | 52.38 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 52.24 | gold quality |
| corpus callosum | UBERON:0002336 | 51.54 | gold quality |
| bone marrow cell | CL:0002092 | 51.33 | silver quality |
| body of pancreas | UBERON:0001150 | 50.68 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.62 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
13 targeting SPINK8, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-5696 | 99.98 | 72.36 | 4487 |
| HSA-MIR-551B-5P | 99.96 | 71.28 | 3493 |
| HSA-MIR-3617-5P | 99.75 | 69.41 | 1968 |
| HSA-MIR-641 | 99.75 | 69.35 | 1975 |
| HSA-MIR-4729 | 99.69 | 72.18 | 4233 |
| HSA-MIR-516B-5P | 99.56 | 66.33 | 1495 |
| HSA-MIR-3614-5P | 99.30 | 65.25 | 837 |
| HSA-MIR-329-5P | 99.27 | 68.11 | 1597 |
| HSA-MIR-4709-3P | 98.88 | 68.04 | 1594 |
| HSA-MIR-222-5P | 98.75 | 69.17 | 1242 |
| HSA-MIR-640 | 98.44 | 66.93 | 644 |
| HSA-MIR-10526-3P | 97.86 | 64.97 | 1342 |
| HSA-MIR-15B-3P | 97.85 | 66.68 | 974 |
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Spink8 | ENSMUSG00000050074 |
| rattus_norvegicus | Spink8 | ENSRNOG00000037199 |
Paralogs (5): SPINK2 (ENSG00000128040), SPINK7 (ENSG00000145879), SPINK14 (ENSG00000196800), SPINK9 (ENSG00000204909), SPINK13 (ENSG00000214510)
Protein
Protein identifiers
Serine protease inhibitor Kazal-type 8 — P0C7L1 (reviewed: P0C7L1)
All UniProt accessions (1): P0C7L1
UniProt curated annotations — full annotation on UniProt →
Function. Probable serine protease inhibitor.
Subcellular location. Secreted.
RefSeq proteins (1): NP_001073994* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR002350 | Kazal_dom | Domain |
| IPR036058 | Kazal_dom_sf | Homologous_superfamily |
Pfam: PF00050
UniProt features (9 total): disulfide bond 3, signal peptide 1, chain 1, domain 1, site 1, glycosylation site 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-P0C7L1-F1 | 80.58 | 0.41 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Catalytic / active sites (1): 51–52 (reactive bond)
Disulfide bonds (3): 42–76, 49–73, 62–94
Glycosylation sites (1): 85
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 40 (showing top):
SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP, GOMF_PEPTIDASE_REGULATOR_ACTIVITY, GOMF_SERINE_TYPE_ENDOPEPTIDASE_INHIBITOR_ACTIVITY, GOMF_ENZYME_INHIBITOR_ACTIVITY, GOMF_ENZYME_REGULATOR_ACTIVITY, GOMF_ENDOPEPTIDASE_REGULATOR_ACTIVITY, chr3p21, MIR5696, MIR4729, MIR4709_3P, MIR222_5P, MIR329_5P, MIR516B_5P, MIR10526_3P, MIR15B_3P
GO Biological Process (0):
GO Molecular Function (3): serine-type endopeptidase inhibitor activity (GO:0004867), protein binding (GO:0005515), peptidase inhibitor activity (GO:0030414)
GO Cellular Component (1): extracellular region (GO:0005576)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| serine-type endopeptidase activity | 1 |
| endopeptidase inhibitor activity | 1 |
| binding | 1 |
| enzyme inhibitor activity | 1 |
| peptidase activity | 1 |
| peptidase regulator activity | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
248 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| SPINK8 | SPINK7 | P58062 | 509 |
| SPINK8 | PNOC | Q13519 | 476 |
| SPINK8 | CAMSAP2 | Q08AD1 | 456 |
| SPINK8 | SPINK14 | Q6IE38 | 454 |
| SPINK8 | USP43 | Q70EL4 | 439 |
| SPINK8 | REG4 | Q9BYZ8 | 426 |
| SPINK8 | CC2D1B | Q5T0F9 | 406 |
| SPINK8 | KRT73 | Q86Y46 | 398 |
| SPINK8 | VWC2 | Q2TAL6 | 384 |
| SPINK8 | SPINK6 | Q6UWN8 | 378 |
| SPINK8 | ARAP2 | Q8WZ64 | 373 |
| SPINK8 | SPINK9 | Q5DT21 | 372 |
| SPINK8 | ADAMTS14 | Q8WXS8 | 368 |
| SPINK8 | MAB21L4 | Q08AI8 | 368 |
| SPINK8 | CRCT1 | Q9UGL9 | 365 |
| SPINK8 | DBNDD1 | Q9H9R9 | 365 |
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: A0A3G5BID2, B4QW11, B5M0W4, D0MVC9, D2CFI7, D3GGZ8, D3ZVP0, E9Q6D8, F5GTK6, O54819, O62247, O97176, P01002, P01003, P01005, P04542, P07701, P08481, P09036, P09655, P09656, P0C7L1, P0DN15, P0DN16, P0DQG8, P10646, P13671, P15358, P19761, P26461, P61134, P61135, P83579, Q02445, Q09TK7, Q11101, Q177W0, Q18206, Q1W4C9, Q20930
Diamond homologs: A2ASQ1, A5YT95, D3ZVP0, O35679, O60575, O62650, O95633, P00995, P00996, P00997, P00998, P01003, P01005, P04542, P05560, P09036, P09655, P09656, P0C7L1, P0DKM8, P0DKM9, P0DKT1, P0DKT2, P0DKT3, P0DKT4, P0DKT5, P10184, P10669, P11706, P16226, P19883, P20155, P21674, P25304, P31514, P31696, P34953, P37109, P47931, P50291
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
9 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 8 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
847 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 3:48328269:A:C | donor_gain | 0.9900 |
| 3:48328271:TCA:T | donor_loss | 0.9900 |
| 3:48328272:CA:C | donor_loss | 0.9900 |
| 3:48328273:A:AC | donor_gain | 0.9900 |
| 3:48328273:A:C | donor_loss | 0.9900 |
| 3:48328274:C:CC | donor_gain | 0.9900 |
| 3:48309903:C:CC | donor_gain | 0.9800 |
| 3:48328269:ACTC:A | donor_loss | 0.9800 |
| 3:48328274:CCA:C | donor_gain | 0.9800 |
| 3:48328274:CCAA:C | donor_gain | 0.9800 |
| 3:48319495:A:AC | donor_gain | 0.9600 |
| 3:48319496:C:CC | donor_gain | 0.9600 |
| 3:48328273:AC:A | donor_gain | 0.9600 |
| 3:48328274:CC:C | donor_gain | 0.9600 |
| 3:48309903:CACA:C | donor_gain | 0.9200 |
| 3:48314185:C:A | donor_gain | 0.9200 |
| 3:48328274:CCAAT:C | donor_gain | 0.9200 |
| 3:48321023:A:AC | donor_gain | 0.9000 |
| 3:48321024:CTA:C | donor_gain | 0.8900 |
| 3:48321024:CTATT:C | donor_gain | 0.8900 |
| 3:48309947:C:CC | acceptor_gain | 0.8600 |
| 3:48319464:T:C | acceptor_gain | 0.8600 |
| 3:48316352:A:AC | donor_gain | 0.8500 |
| 3:48307014:AGTAT:A | acceptor_gain | 0.8200 |
| 3:48319496:CAGA:C | donor_gain | 0.8100 |
| 3:48321732:TGA:T | donor_gain | 0.8100 |
| 3:48307001:TTCC:T | acceptor_loss | 0.7900 |
| 3:48307006:G:C | acceptor_loss | 0.7900 |
| 3:48309895:TTTAC:T | donor_loss | 0.7900 |
| 3:48309899:CTTA:C | donor_loss | 0.7900 |
AlphaMissense
646 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 3:48319551:C:G | C62S | 0.973 |
| 3:48319552:A:T | C62S | 0.973 |
| 3:48309905:C:G | C94S | 0.964 |
| 3:48309906:A:T | C94S | 0.964 |
| 3:48319548:C:T | G63D | 0.947 |
| 3:48319518:C:G | C73S | 0.944 |
| 3:48319519:A:T | C73S | 0.944 |
| 3:48319512:A:G | L75P | 0.940 |
| 3:48319509:C:G | C76S | 0.936 |
| 3:48319510:A:T | C76S | 0.936 |
| 3:48319551:C:T | C62Y | 0.931 |
| 3:48319610:G:C | C42W | 0.929 |
| 3:48319519:A:G | C73R | 0.927 |
| 3:48319542:T:G | D65A | 0.926 |
| 3:48319550:A:C | C62W | 0.926 |
| 3:48319611:C:G | C42S | 0.922 |
| 3:48319612:A:T | C42S | 0.922 |
| 3:48319552:A:G | C62R | 0.921 |
| 3:48319543:C:G | D65H | 0.917 |
| 3:48319531:A:C | Y69D | 0.912 |
| 3:48319552:A:C | C62G | 0.910 |
| 3:48319508:G:C | C76W | 0.909 |
| 3:48319542:T:A | D65V | 0.909 |
| 3:48309904:A:C | C94W | 0.908 |
| 3:48319510:A:G | C76R | 0.908 |
| 3:48319517:G:C | C73W | 0.908 |
| 3:48309906:A:G | C94R | 0.907 |
| 3:48319530:T:C | Y69C | 0.906 |
| 3:48319612:A:G | C42R | 0.906 |
| 3:48319518:C:T | C73Y | 0.904 |
dbSNP variants (sampled 300 via entrez): RS1000086144 (3:48318574 C>T), RS1000153344 (3:48317263 C>A,T), RS1000196982 (3:48311703 A>C), RS1000429565 (3:48314394 C>T), RS1000476068 (3:48330465 G>A), RS1000521238 (3:48335501 G>A), RS1000532727 (3:48313420 T>C), RS1000921719 (3:48320150 A>C,G), RS1001107280 (3:48325752 C>A,G), RS1001297037 (3:48329694 T>C), RS1001442564 (3:48327559 G>C), RS1001515326 (3:48310550 T>G), RS1001554965 (3:48327869 A>G), RS1002070919 (3:48321816 A>G), RS1002358113 (3:48321584 G>T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
6 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST010242_31 | HDL cholesterol levels | 7.000000e-16 |
| GCST010698_80 | Subcortical volume (min-P) | 3.000000e-24 |
| GCST010699_110 | Brain morphology (min-P) | 4.000000e-08 |
| GCST010701_52 | Cortical surface area (MOSTest) | 1.000000e-16 |
| GCST010702_36 | Subcortical volume (MOSTest) | 1.000000e-10 |
| GCST010703_262 | Brain morphology (MOSTest) | 2.000000e-13 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004612 | high density lipoprotein cholesterol measurement |
| EFO:0004346 | neuroimaging measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
3 total (human), top 3 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | increases methylation | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Valproic Acid | decreases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.